Good Distribution Practice (GDP)

What is Good Distribution Practice (GDP)

Good Distribution Practice (GDP) consists of guidelines ensuring that pharmaceutical and life science products are consistently stored, transported, and handled under suitable conditions. GDP aims to preserve product quality, safety, and efficacy throughout supply chain logistics.

Why It Matters

GDP compliance protects patient safety by ensuring medications and biologics arrive as intended. It reduces risks such as temperature excursions, product contamination, or mislabeling. Regulatory authorities worldwide, including the FDA and EMA, require GDP adherence for all pharmaceutical distributors.

Key GDP Requirements

GDP standards include maintaining traceability through batch records, conducting temperature and humidity monitoring, and enforcing secure transportation routes. Companies must perform regular risk assessments and monitor environmental conditions in real-time. Staff must receive training to handle pharmaceuticals and medical samples in line with GDP protocols.

Common GDP Misconceptions

Some believe GDP applies only to medicines, but it also covers biologics, clinical trial samples, and diagnostics kits. Another myth is that simple packaging is enough; however, proper documentation, equipment validation, and consistent quality control are mandatory under GDP.

Mercury’s GDP-Compliant Services

Mercury operates its temperature-controlled fleet and monitoring systems under GDP standards. We use calibrated sensors and validated containers to ensure integrity throughout transit. Mercury also maintains all documentation and audit trails required for regulatory inspections.

Frequently Asked Questions

Q: How does GDP differ from cold chain shipping?

A: Cold chain shipping ensures temperature control, while GDP includes broader quality controls—like documentation, risk management, and secure distribution paths—under regulatory oversight.

Q: Will Mercury’s proof of delivery satisfy GDP audits?

A: Yes. Mercury provides detailed shipment logs, temperature and humidity data, chain-of-custody records, and signed delivery confirmations suitable for GDP audits.

Q: Can GDP procedures adapt for clinical trial materials?

A: Absolutely. Mercury’s GDP framework accommodates clinical trial samples and investigational drugs. We customize monitoring, packaging validation, and documentation based on trial protocols and drug stability requirements.

Mercury empowers pharmaceutical, biotech, and diagnostic firms to manage compliant distribution without dividing internal resources. Our GDP-compliant solutions let you focus on research and patient outcomes—not logistics. Read more on our website to learn more about how Good Distribution Practice safeguards your regulated shipments.

Ensure your sensitive pharmaceutical and clinical shipments meet the highest compliance standards. Partner with Mercury for fully GDP-compliant logistics that protect your products and reputation. Contact us today to streamline your distribution with confidence.